The antiemetic interaction of Δ9-tetrahydrocannabinol when combined with tropisetron or dexamethasone in the least shrew
- 9 August 2008
- journal article
- Published by Elsevier in Pharmacology Biochemistry and Behavior
- Vol. 91 (3) , 367-373
- https://doi.org/10.1016/j.pbb.2008.08.008
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- Utilization of the least shrew as a rapid and selective screening model for the antiemetic potential and brain penetration of substance P and NK1 receptor antagonistsBrain Research, 2008
- Differential involvement of neurotransmitters through the time course of cisplatin-induced emesis as revealed by therapy with specific receptor antagonistsEuropean Journal Of Cancer, 2003
- Physiology of Chemotherapy-Induced Emesis and Antiemetic TherapyDrugs, 1997
- Effect of cisplatin on dopamine release from PC12 cellsLife Sciences, 1996
- An efficient new cannabinoid antiemetic in pediatric oncologyLife Sciences, 1995
- Efficacy and tolerability of tropisetron in comparison with a combination of tropisetron and dexamethasone in the control of nausea and vomiting induced by cisplatin-containing chemotherapyEuropean Journal Of Cancer, 1994
- TropisetronDrugs, 1992
- OndansetronDrugs, 1991
- Optimum Management of Nausea and Vomiting in Cancer ChemotherapyDrugs, 1987
- Cannabinoids in the Management of Severe Nausea and Vomiting from Cancer Chemotherapy. Some Additional ConsiderationsThe Journal of Clinical Pharmacology, 1981